SUSTAIN 340B Act
The source supplies the latest action, but no lifecycle stage.
Latest action (5 Aug 2026): Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
What this bill does
S. 5244 would amend the Public Health Service Act's provisions governing the 340B drug discount program, though the specific changes it would make are not yet available in the published bill text. Since the bill was introduced on 2026-08-05 without accompanying legislative text, only its title, sponsor, and status are currently known.
The 340B program allows certain hospitals and other healthcare providers serving low-income or vulnerable populations to purchase outpatient drugs from manufacturers at reduced prices. Because the bill's specific provisions are not yet public, it is not possible to say which participants — providers, drug manufacturers, or patients — would be affected or how, until the full text is released.
The bill was introduced in the Senate on 2026-08-05 by Sen. Jerry Moran (R-KS) and referred to committee, which is the standard next step for a newly introduced bill. Its current status is "Introduced," meaning it has not yet been scheduled for a committee vote, floor vote, or further action. Further progress — including release of the full bill text, committee consideration, and possible amendments — would need to occur before its effects can be assessed in detail.
Plain-English summary generated by Bill100 AI from the official record. Always verify against the source below.
Timeline
5 Aug 2026
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Common questions
- What does S. 5244 do?
- S. 5244 would amend the Public Health Service Act's provisions governing the 340B drug discount program, though the specific changes it would make are not yet available in the published bill text. Since the bill was introduced on 2026-08-05 without accompanying legislative text, only its title, sponsor, and status are currently known. The 340B program allows certain hospitals and other healthcare providers serving low-income or vulnerable populations to purchase outpatient drugs from manufacturers at reduced prices. Because the bill's specific provisions are not yet public, it is not possible to say which participants — providers, drug manufacturers, or patients — would be affected or how, until the full text is released. The bill was introduced in the Senate on 2026-08-05 by Sen. Jerry Moran (R-KS) and referred to committee, which is the standard next step for a newly introduced bill. Its current status is "Introduced," meaning it has not yet been scheduled for a committee vote, floor vote, or further action. Further progress — including release of the full bill text, committee consideration, and possible amendments — would need to occur before its effects can be assessed in detail.
- Has S. 5244 become law?
- The source does not supply a confirmed lifecycle stage for S. 5244. Check the latest action and official source below.
- Who sponsored S. 5244?
- S. 5244 was sponsored by Sen. Moran, Jerry [R-KS] (R-KS), with 5 cosponsors.
- What's the latest action on S. 5244?
- Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (5 Aug 2026).
Related bills in Health
Choices for Increased Mobility Act of 2026
Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026
Access to Medical Supplies Act
Lower Premiums, Faster Payments Act
More bills from Sen. Moran, Jerry [R-KS]
A resolution relating to the death of the Honorable Nancy Kassebaum, former United States Senator for the State of Kansas.
Fair Audits and Inspections for Regulators' Exams Act
A resolution honoring and commending the 100th anniversary of the Golf Course Superintendents Association of America.
Runway SAFE-T Act
Bill100 mirrors the public U.S. legislative record from Congress.gov and GovTrack and adds plain-English AI summaries. It is an information tool, not legal, compliance or lobbying advice, and it is not affiliated with the U.S. Congress or any government agency. AI summaries can simplify or omit detail — every bill links to the official source; verify there before you rely on it.